M Ravic, A Johnston, P Turner
Index: Postgrad. Med. J. 66 Suppl 4 , S30-4, (1990)
Full Text: HTML
A series of studies in human subjects of potential interactions of lornoxicam with some other drugs is reviewed. No evidence of kinetic interaction was found with the antacids Maalox or Solugastrol, nor was there evidence of influence on antipyrine clearance. Lornoxicam reduced warfarin clearance and enhanced its hypoprothrombinaemic effect. It did not influence glibenclamide kinetics, but plasma insulin concentrations were significantly higher and plasma glucose concentrations significantly lower when lornoxicam and glibenclamide were co-administered. Lornoxicam produced a modest reduction in digoxin clearance, but no other clear evidence of interaction was seen. Lornoxicam significantly antagonized the diuretic and natriuretic actions of frusemide.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Lornoxicam
CAS:70374-39-9 |
C13H10ClN3O4S2 |
|
Intra-articular levobupivacaine, lornoxicam and morphine ana...
2012-01-01 [Acta Orthop. Traumatol. Turc. 46(6) , 411-5, (2012)] |
|
Characterization of two polymorphs of lornoxicam.
2013-01-01 [J. Pharm. Pharmacol. 65(1) , 44-52, (2013)] |
|
Investigation on the micelle-sensitized Ce(IV)-lornoxicam-Rh...
2012-01-01 [J. Fluoresc. 22(1) , 529-35, (2012)] |
|
Enhanced targeting efficiency of PLGA microspheres loaded wi...
2011-01-01 [Drug Deliv. 18(7) , 536-44, (2011)] |
|
Overview of the pharmacological properties, pharmacokinetics...
1990-01-01 [Postgrad. Med. J. 66 Suppl 4 , S18-21, (1990)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
